Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant
Clinical trial NCT07050160 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07050160
- Sponsor
- Lexeo Therapeutics
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-29
- Primary completion
- 2030-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.